The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
When poor solubility becomes an issue: From early stage to proof of concept
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Vishweshwar, P., McMahon, J. A., Bis, J. A., & Zaworotko, M. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20578 · Cited by 968
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 742
Kalantzi, L., Goumas, K., Kalioras, V., Abrahamsson, B., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-8476-1 · Cited by 658
Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Kang, B. K., Lee, J. S., Chon, S. K., Jeong, S. Y., Yuk, S. H., Khang, G., Lee, H. B., & Cho, S. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.028 · Cited by 545
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Blanquet, S., Zeijdner, E., Beyssac, E., Meunier, J.-P., Denis, S., Havenaar, R., & Alric, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022404.70478.4b · Cited by 282
Kerns, E. H., Di, L., Petusky, S., Farris, M., Ley, R., & Jupp, P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20075 · Cited by 275
Peeters, J., Neeskens, P., Tollenaere, J. P., Van Remoortere, P., & Brewster, M. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10126 · Cited by 272
Nonionic oil-in-water microemulsions: the effect of oil type on phase behaviour
Warisnoicharoen, W., Lansley, A. B., & Lawrence, M. J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00406-8 · Cited by 268
IAM chromatography: an in vitro screen for predicting drug membrane permeability
Pidgeon, C., Ong, S., Liu, H., Qiu, X., Pidgeon, M., Dantzig, A. H., Munroe, J., Hornback, W. J., & Kasher, J. S. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00004a004 · Cited by 267
Persson, E. M., Gustafsson, A.-S., Carlsson, A. S., Nilsson, R. G., Knutson, L., Forsell, P., Hanisch, G., Lennernäs, H., & Abrahamsson, B. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8192-x · Cited by 266
Oh, D.-M., Curl, R. L., & Amidon, G. L. (1993) · Pharmaceutical Research · doi:10.1023/a:1018947113238 · Cited by 253
Porter, C. J. H., Kaukonen, A. M., Boyd, B. J., Edwards, G. A., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036914.22132.cc · Cited by 242
Role of Caco-2 Cell Monolayers in Prediction of Intestinal Drug Absorption
Shah, P., Jogani, V., Bagchi, T., & Misra, A. (2006) · Biotechnology Progress · doi:10.1021/bp050208u · Cited by 233
Strategies for particle design using supercritical fluid technologies
York, P. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00209-6 · Cited by 232
Lipids, Lipophilic Drugs, and Oral Drug Delivery—Some Emerging Concepts
Charman, W. N. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<967::aid-jps1>3.0.co;2-r · Cited by 224
Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models
LennernÄs, H. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06084.x · Cited by 223
Avdeef, A. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.2.325 · Cited by 222
Nicolaides, E., Symillides, M., Dressman, J. B., & Reppas, C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011071401306 · Cited by 208
Gao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., & Lu, Q. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028718 · Cited by 208
Kaukonen, A. M., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016282.77887.1f · Cited by 206
Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man
Lennernäs, H., Ahrenstedt, Ö., Hällgren, R., Knutson, L., Ryde, M., & Paalzow, L. K. (1992) · Pharmaceutical Research · doi:10.1023/a:1015888813741 · Cited by 202
Amorphous Drug Nanosuspensions. 1. Inhibition of Ostwald Ripening
Lindfors, L., Skantze, P., Skantze, U., Rasmusson, M., Zackrisson, A., & Olsson, U. (2006) · Langmuir · doi:10.1021/la0523661 · Cited by 197
Richelle, M., Enslen, M., Hager, C., Groux, M., Tavazzi, I., Godin, J.-P., Berger, A., Métairon, S., Quaile, S., Piguet-Welsch, C., et al. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.171 · Cited by 186
An Integrated Model for Determining Causes of Poor Oral Drug Absorption
Yu, L. X. (1999) · Pharmaceutical Research · doi:10.1023/a:1018911728161 · Cited by 185
Kalantzi, L., Persson, E., Polentarutti, B., Abrahamsson, B., Goumas, K., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0207-8 · Cited by 159
Khoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 150
Richelle, M., Bortlik, K., Hager, C., Lambelet, P., Baur, M., Offord, E., Liardet, S., & Applegate, L. A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.3.404 · Cited by 143
Impact of the intragastric location of extended release tablets on food interactions
Weitschies, W., Wedemeyer, R., Kosch, O., Fach, K., Nagel, S., Söderlind, E., Trahms, L., Abrahamsson, B., & Mönnikes, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.018 · Cited by 131
Kaukonen, A. M., Boyd, B. J., Charman, W. N., & Porter, C. J. H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016283.87709.a9 · Cited by 121
Khoo, S., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1110 · Cited by 111
Kuentz, M., Nick, S., Parrott, N. J., & Röthlisberger, D. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.011 · Cited by 108
Success in translational research: lessons from the development of bortezomib
Sánchez‐Serrano, I. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1959 · Cited by 103
Amorphous Drug Nanosuspensions. 2. Experimental Determination of Bulk Monomer Concentrations
Lindfors, L., Forssén, S., Skantze, P., et al. (2005) · Langmuir · doi:10.1021/la052367t · Cited by 98
Schulze, J. D. R., Waddington, W. A., Ell, P. J., Parsons, G. E., Coffin, M. D., & Basit, A. W. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008046.64409.bd · Cited by 83
van Drooge, D. J., Hinrichs, W. L. J., & Frijlink, H. W. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10590 · Cited by 77
Magnetic marker monitoring of disintegrating capsules
Weitschies, W., Karaus, M., Cordini, D., Trahms, L., Breitkreutz, J., & Semmler, W. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00140-3 · Cited by 65
Computer prediction of crystal morphology
Rohl, A. L. (2003) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(03)00019-6 · Cited by 63
A case for prodrugs: Fosphenytoin
Stella, V. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00112-k · Cited by 62
The Interaction of Lipophilic Drugs with Intestinal Fatty Acid-binding Protein
Velkov, T., Chuang, S., Wielens, J., Sakellaris, H., Charman, W. N., Porter, C. J. H., & Scanlon, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410193200 · Cited by 61
Johnson, K. C. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120024179 · Cited by 59
The Lymph Lipid Precursor Pool Is a Key Determinant of Intestinal Lymphatic Drug Transport
Trevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094094 · Cited by 49
Bile Increases Intestinal Lymphatic Drug Transport in the Fasted Rat
Trevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6808-9 · Cited by 46
Stella, V. J., Martodihardjo, S., Terada, K., & Rao, V. M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980008v · Cited by 41
Improved early clinical development through human microdosing studies
Wilding, I. R., & Bell, J. A. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03509-9 · Cited by 40
Trevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008102 · Cited by 37
Khoo, S., Prankerd, R. J., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10045 · Cited by 36
Stella, V. J., Rao, V. M., & Martodihardjo, S. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980489i · Cited by 28
Cited by
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690
Ishikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Merisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Metadata
- Authors
- Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 31
- Issue
- 5
- Pages
- 249-261
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2041070822
- Cited by
- 567
- References
- 55
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.